CHARACTERIZING THE USE OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE

被引：0
|
作者：
Pajoumand, Mehrnaz
Chaney, Whitney
Mueller, Scott
Shafeeq, Hira
Daley, Mitchell
Stump, Brian
Hines, Michelle
Rech, Megan
Stein, Deborah
机构：
[1] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[2] Univ Colorado Denver, Aurora, CO USA
[3] St Johns Univ, Valley Stream, NY USA
[4] Univ Texas Austin, Seton Famiy Healthcare, Austin, TX 78712 USA
[5] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[6] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
CRITICAL CARE MEDICINE | 2018年 / 46卷 / 01期
关键词：
D O I：
10.1097/01.ccm.0000528580.60916.80
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
564
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [31] EVALUATION OF WARFARIN REVERSAL WITH 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE COMPARED TO 3-FACTOR PROTHROMBIN COMPLEX CONCENTRATE AT A TERTIARY ACADEMIC MEDICAL CENTER
    Al-Majzoub, Omar
    Rybak, Eva
    Reardon, David P.
    Krause, Patricia
    Connors, Jean M.
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01): : 7 - 13
  • [32] Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate
    Jansma, Brianna
    Montgomery, Josephine
    Dietrich, Scott
    Mixon, Mark A.
    Peksa, Gary D.
    Faine, Brett
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (11) : 1090 - 1095
  • [33] PULMONARY EMBOLISM FOLLOWING RECEIPT OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN A TRAUMA PATIENT
    Thomas, Zachariah
    Van Ness, Brian
    LoCurto, John, Jr.
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [34] Rivaroxaban-Associated Intraparenchymal Hemorrhage Managed with 4-Factor Prothrombin Complex Concentrate
    Patel, Jayme S. K.
    Rahbar, Aryan J.
    Patel, Ketan
    Sigal, Tiffany W.
    [J]. CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS, 2018, 6 (02): : 62 - 68
  • [35] TWENTY YEARS OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE: REVIEW AND ADVANCES OF OCTAPLEX/BALFAXAR
    Gareis, Michelle
    Sarode, Ravindra
    Mehta-Shah, Trupti
    Goldstein, Joshua
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [36] Rivaroxaban-Associated Intraparenchymal Hemorrhage Managed with 4-Factor Prothrombin Complex Concentrate
    Jayme S. K. Patel
    Aryan J. Rahbar
    Ketan Patel
    Tiffany W. Sigal
    [J]. Current Emergency and Hospital Medicine Reports, 2018, 6 (2) : 62 - 68
  • [37] Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal
    Klein, Lauren
    Peters, Jessica
    Miner, James
    Gorlin, Jed
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (09): : 1213 - 1218
  • [38] IN-VIVO REVERSAL OF THE ANTICOAGULANT EFFECT OF APIXABAN WITH 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE
    Cheung, Y. W.
    Barco, S. L.
    Hutten, B. A.
    Meijers, J. C.
    Middeldorp, S.
    Coppens, M.
    [J]. HAEMATOLOGICA, 2014, 99 : 482 - 482
  • [39] Clinical Applications of 4-Factor Prothrombin Complex Concentrate A Practical Pathologist's Perspective
    Unold, David
    Tormey, Christopher A.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (12) : 1568 - 1575
  • [40] FIXED-DOSE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE ADMINISTRATION: IN SEARCH OF THE OPTIMAL DOSING
    Mishra, Ajay Kumar
    Sahu, Kamal Kant
    John, Kevin
    Lal, Amos
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2020, 59 (02): : 313 - 314
12345